These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33617676)

  • 1. Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
    Tefferi A; Szuber N; Pardanani A; Hanson CA; Vannucchi AM; Barbui T; Gangat N
    Am J Hematol; 2021 Jun; 96(6):E182-E184. PubMed ID: 33617676
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
    Alvarez-Larrán A; Pereira A; Guglielmelli P; Hernández-Boluda JC; Arellano-Rodrigo E; Ferrer-Marín F; Samah A; Griesshammer M; Kerguelen A; Andreasson B; Burgaleta C; Schwarz J; García-Gutiérrez V; Ayala R; Barba P; Gómez-Casares MT; Paoli C; Drexler B; Zweegman S; McMullin MF; Samuelsson J; Harrison C; Cervantes F; Vannucchi AM; Besses C
    Haematologica; 2016 Aug; 101(8):926-31. PubMed ID: 27175028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenomegaly and thrombosis risk in essential thrombocythemia: the Mayo Clinic experience.
    Haider M; Gangat N; Hanson C; Tefferi A
    Am J Hematol; 2016 May; 91(5):E296-7. PubMed ID: 26875150
    [No Abstract]   [Full Text] [Related]  

  • 4. Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2(V617F) mutational status.
    Ohyashiki K; Akahane D; Gotoh A; Ito Y; Tauchi T; Miyazawa K; Kimura Y; Ohyashiki JH
    Leukemia; 2007 Dec; 21(12):2544-5. PubMed ID: 17611562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of essential thrombocythemia].
    Alvarez-Larrán A; Cervantes F; Besses C
    Med Clin (Barc); 2013 Sep; 141(6):260-4. PubMed ID: 23490491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
    Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Colomer D; Villamor N; Bellosillo B; Cervantes F
    Am J Hematol; 2009 Feb; 84(2):102-8. PubMed ID: 19105233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.
    Godfrey AL; Campbell PJ; MacLean C; Buck G; Cook J; Temple J; Wilkins BS; Wheatley K; Nangalia J; Grinfeld J; McMullin MF; Forsyth C; Kiladjian JJ; Green AR; Harrison CN; ; ; ;
    J Clin Oncol; 2018 Dec; 36(34):3361-3369. PubMed ID: 30153096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between thrombotic risk scores in essential thrombocythemia and survival implications.
    Santoro M; Accurso V; Mancuso S; Carlisi M; Raso S; Tarantino G; Di Piazza F; Perez A; Russo A; Siragusa S
    Hematol Oncol; 2019 Oct; 37(4):434-437. PubMed ID: 31465530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):247-51. PubMed ID: 10726022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia.
    Cacciola RR; Di Francesco E; Pezzella F; Tibullo D; Giustolisi R; Cacciola E
    Acta Haematol; 2007; 118(4):215-8. PubMed ID: 18057866
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
    Landolfi R; Di Gennaro L
    Haematologica; 2008 Mar; 93(3):331-5. PubMed ID: 18310537
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin in essential thrombocythemia: status quo and quo vadis.
    Griesshammer M; Bangerter M; van Vliet HH; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):371-7. PubMed ID: 9263354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia.
    Chen CC; Gau JP; Chou HJ; You JY; Huang CE; Chen YY; Lung J; Chou YS; Leu YW; Lu CH; Lee KD; Tsai YH
    Ann Hematol; 2014 Dec; 93(12):2029-36. PubMed ID: 25015052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: challenges in the management of thrombocytosis in young patients.
    Robinson S; Harrison C
    Clin Adv Hematol Oncol; 2008 Feb; 6(2):137-8, 141. PubMed ID: 18347565
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies.
    Passamonti F; Rumi E; Randi ML; Morra E; Cazzola M
    J Thromb Haemost; 2010 Feb; 8(2):411-3. PubMed ID: 19912517
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.
    Randi ML; Bertozzi I; Rumi E; Elena C; Finazzi G; Vianelli N; Polverelli N; Ruggeri M; Vannucchi AM; Antonioli E; Lussana F; Tieghi A; Iurlo A; Elli E; Ruella M; Fabris F; Cazzola M; Barbui T
    Am J Hematol; 2014 Mar; 89(3):306-9. PubMed ID: 24265194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young platelet millionaires with essential thrombocythemia.
    Gangat N; Szuber N; Jawaid T; Hanson CA; Pardanani A; Tefferi A
    Am J Hematol; 2021 Apr; 96(4):E93-E95. PubMed ID: 33524176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.